JPMorgan Chase & Co. Sells 31,410 Shares of Ingredion Incorporated $INGR

JPMorgan Chase & Co. decreased its stake in Ingredion Incorporated (NYSE:INGR) by 7.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 393,923 shares of the company’s stock after selling 31,410 shares during the period. JPMorgan Chase & Co. owned 0.62% of Ingredion worth $48,102,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Integrated Wealth Concepts LLC grew its stake in Ingredion by 32.8% in the first quarter. Integrated Wealth Concepts LLC now owns 2,082 shares of the company’s stock valued at $281,000 after purchasing an additional 514 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Ingredion by 63.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,694 shares of the company’s stock worth $499,000 after purchasing an additional 1,440 shares in the last quarter. NewEdge Advisors LLC raised its stake in shares of Ingredion by 9.0% during the 1st quarter. NewEdge Advisors LLC now owns 9,687 shares of the company’s stock worth $1,310,000 after purchasing an additional 797 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Ingredion by 5.5% in the first quarter. Goldman Sachs Group Inc. now owns 101,414 shares of the company’s stock valued at $13,712,000 after acquiring an additional 5,255 shares during the last quarter. Finally, Focus Partners Wealth lifted its stake in Ingredion by 5.6% in the 1st quarter. Focus Partners Wealth now owns 3,636 shares of the company’s stock valued at $492,000 after purchasing an additional 192 shares during the last quarter. Institutional investors and hedge funds own 85.27% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on INGR shares. Stephens reaffirmed an “equal weight” rating and set a $120.00 price target on shares of Ingredion in a report on Wednesday, February 4th. Jefferies Financial Group reissued a “hold” rating on shares of Ingredion in a research report on Wednesday, February 4th. Barclays upped their target price on Ingredion from $124.00 to $128.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. Zacks Research upgraded shares of Ingredion from a “strong sell” rating to a “hold” rating in a research note on Monday, December 22nd. Finally, UBS Group boosted their price target on Ingredion from $119.00 to $124.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Two research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $126.43.

Insider Activity

In related news, VP Davida Marie Gable sold 375 shares of Ingredion stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $112.44, for a total value of $42,165.00. Following the completion of the transaction, the vice president directly owned 7,110 shares in the company, valued at approximately $799,448.40. The trade was a 5.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO James P. Zallie sold 9,958 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $116.55, for a total transaction of $1,160,604.90. Following the sale, the chief executive officer directly owned 33,011 shares in the company, valued at $3,847,432.05. The trade was a 23.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 48,685 shares of company stock valued at $5,783,898 over the last quarter. Company insiders own 2.30% of the company’s stock.

Ingredion Stock Down 1.0%

Shares of NYSE INGR opened at $109.18 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.66 and a quick ratio of 1.73. The stock has a market capitalization of $6.87 billion, a PE ratio of 9.78, a P/E/G ratio of 0.87 and a beta of 0.69. Ingredion Incorporated has a one year low of $102.31 and a one year high of $141.78. The business’s fifty day moving average price is $115.76 and its 200-day moving average price is $115.43.

Ingredion (NYSE:INGR) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $2.53 earnings per share for the quarter, missing the consensus estimate of $2.59 by ($0.06). The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.78 billion. Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The company’s revenue was down 2.4% compared to the same quarter last year. During the same period last year, the business posted $2.63 EPS. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. On average, equities research analysts anticipate that Ingredion Incorporated will post 11.14 EPS for the current year.

Ingredion Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 21st. Stockholders of record on Wednesday, April 1st will be paid a $0.82 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $3.28 annualized dividend and a dividend yield of 3.0%. Ingredion’s dividend payout ratio (DPR) is presently 29.39%.

Ingredion News Summary

Here are the key news stories impacting Ingredion this week:

• Positive Sentiment: Ingredion was named one of the 2026 “World’s Most Ethical Companies,” a reputational win that can support investor confidence and appeal to ESG-focused funds. Ingredion Named One of the 2026 World’s Most Ethical Companies
• Positive Sentiment: Ingredion formed an alliance with Shiru to use AI-designed proteins, signaling a strategic push into higher-value nutrition and specialty ingredients that could lift long‑term margins if commercialization succeeds. Ingredion Taps Shiru AI Proteins To Shift Toward Higher Value Nutrition
• Positive Sentiment: Analyst and thematic attention: Zacks highlighted Ingredion among three AgTech/food-innovation picks, reinforcing the narrative that the company is moving beyond commodity starch/sweetener exposure toward science-driven growth. 3 AgTech & Food Innovation Picks Riding on Structural Growth Trends
• Positive Sentiment: Benchmark initiated coverage with a Buy rating and $130 target, adding incremental buy-side analyst support that may underpin upside if results improve. Ingredion (NYSE:INGR) Coverage Initiated at Benchmark
• Positive Sentiment: Dividend: the board declared a $0.82 quarterly dividend (annualized $3.28, ~3.0% yield), supporting income investors and signaling cash-flow confidence.
• Negative Sentiment: Insider selling: VP Davida Marie Gable sold 375 shares at about $112.44 on March 18; while a small dollar amount, insider sales can be read negatively by short‑term traders. Davida Marie Gable Sells 375 Shares of Ingredion (NYSE:INGR) Stock

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.